SV

Street Verdict

Analyst Scorecard

DOLPHMED.BO · BSE

DOLPHIN MEDICAL SERVICES LTD.

₹7.83

+4.96% (+₹0.37)

Prev. close

₹7.46

Volume

54,106

As of

16 Nov 2026

Price history

₹7.83+₹5.47 (+231.78%) · 3M
18 Aug 2025 → 16 Nov 2026
345678918 Aug08 Dec06 Apr27 Jul16 Nov
Daily closes · updates after each session

Analyst sentiment

No analyst stances in this range

0 analyst stances · last 90 days · one per analyst

Try a wider range — no analyst has covered this yet.

Explore by date range →

Analyst opinions

No analyst calls on DOLPHIN MEDICAL SERVICES LTD. yet.

Fundamentals

About DOLPHIN MEDICAL SERVICES LTD.

Dolphin Medical Services Limited engages in the provision of diagnostics and other allied services in India. Dolphin Medical Services Limited was incorporated in 1992 and is based in Vijayawada, India.

Details

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Vijayawada

Key stats

Market cap

₹2.84 Cr

P/E ratio (TTM)

54.7

Dividend yield

0.00%

EPS (TTM)

₹0.13

Beta (1Y · daily vs NIFTY 50)

-0.09

Beta (5Y · monthly vs NIFTY 50)

0.10

Shares float

11.90 L

EPS · quarter ended Jun 2026

₹0.11

Financial Performance

01 · Financials

-0.5 Cr0 Cr0.5 Cr1 Cr₹-100%-50%0%50%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

-0.1-0.0500.05₹FY23FY24FY25FY26

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-100%0%100%200%FY21FY22FY23FY24FY25FY26
SalesFixed assetsInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr5 Cr10 Cr15 Cr₹0×0.03×0.05×0.07×0.1×FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr5 Cr10 Cr15 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-0.5 Cr0 Cr0.5 Cr1 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

Total assets for FY22: from the company's own statements, which the series had none for. Current assets for FY22: from the company's own statements, which the series had none for. Equity for FY22: from the company's own statements, which the series had none for. Inventory for FY22: from the company's own statements, which the series had none for. Cash for FY22: from the company's own statements, which the series had none for.

08 · Profit & Loss — as filed

Annual

Line itemFY23FY24FY25
₹64.80 L₹71.54 L₹81.63 L
Cost of materials consumed
₹9.16 L₹11.07 L₹11.56 L
Employee benefit expense
₹7.19 L₹8.47 L₹6.60 L
Financial Costs
₹92,923₹95,488.31₹95,488.31
Depreciation and amortization expense
₹6.27 L₹4.65 L₹6.27 L
Other expenses
₹53.01 L₹56.04 L₹59.27 L
Total Expenses
₹76.56 L₹81.18 L₹84.66 L
3. Profit/(Loss) before exceptional items and tax
₹-11.76 L₹-9.64 L₹-3.04 L
4. Exceptional items
₹0——
5. Profit/(Loss) before tax
₹-11.76 L₹-9.64 L₹-3.04 L
₹69,708₹76,365₹34,374
10. Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement
₹0——
11. Net Profit/(Loss) for the period from continuing operations
₹-12.46 L₹-10.40 L₹-3.38 L
12. Profit/(loss) from discontinued operations before tax
₹0——
13. Tax expense of discontinued operations
₹0——
14. Net Profit/(loss) from discontinuing operations before tax
₹0——
15. Net profit/(Loss) for the period
₹-12.46 L₹-10.40 L₹-3.38 L
16. Other comprehensive income net of taxes
₹0——
17. Total Comprehensive Income/(Loss) for the period
₹-12.46 L₹-10.40 L₹-3.38 L
Basic earnings (loss) per share
0.00-0.07-0.02
Diluted earnings (loss) per share
0.00-0.07-0.02

The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.

All years: standalone statements.

09 · Balance Sheet — as filed

Annual

Line itemFY23FY24FY25
₹10.21 Cr₹10.16 Cr₹10.10 Cr
₹1.96 Cr₹1.97 Cr₹1.98 Cr
3 Non-current assets classified as held for sale
₹0——
₹12.17 Cr₹12.13 Cr₹12.08 Cr
₹10.18 Cr₹10.07 Cr₹10.04 Cr
₹1.34 Cr₹1.39 Cr₹1.46 Cr
₹65.78 L₹66.60 L₹57.62 L
Liabilities directly associated with assets in disposal group
₹0——
Regulatory deferral account credit balances and related deferred
₹0——
₹12.17 Cr₹12.13 Cr₹12.08 Cr

The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.

All years: standalone statements.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
——₹-5₹-4.50 L₹-5.97 L₹13.60 L
Investing cash flow
——₹0₹0₹0₹-45.40 L
——₹5₹4.78 L₹6.34 L₹31.32 L
Capital expenditure
—————₹-45.40 L
End cash position
——₹1.65 L₹1.65 L₹2.02 L₹1.54 L

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
DOLPHIN MEDICAL SERVICES LTD.₹2.84 Cr₹7.1154.70.280.4%0.09-3.8%+240.2%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

DOLPHMED.BO

Dolphin Medical Services Limited Reports Earnings Results for the Half Year Ended September 30, 2026

www.marketscreener.com · 8 days ago